Xaira Therapeutics, a company built to transform drug discovery through AI, today announced X-Cell, its first virtual cell ...

LaBonne is president of the Society for Developmental Biology and the Erastus Otis Haven professor of molecular biosciences at Northwestern University. Imagine a world without lifesaving medicines, ...

Partnership aims to accelerate precision immunotherapy by leveraging AI-powered virtual cell models to identify which patients are most likely to benefit from BOT/BAL treatment Collaboration builds on ...

Join ELRIG at the Advances in Cell-based Screening 2026 for key insights into drug discovery from top scientists.

Graham Johnson, a computational biologist and scientific illustrator at the Allen Institute for Cell Science, recalls ...

The lab as we know it today is being transformed by how we think about medical research and drug discovery, as well as the intersection of artificial intelligence and biotechnology. As someone who has ...

One of the holy grails of biology is digitally simulating a living cell. If researchers can use computers to more accurately understand how new medicines would react in the body, that could give them ...

The competition, hosted by Arc Institute at virtualcellchallenge.org and sponsored by NVIDIA, 10x Genomics, and Ultima Genomics, is focused on accelerating progress in AI modeling of biology. For the ...

Biologics and cell therapy programs are under increasing pressure to deliver high‑quality cell lines and physiologically ...

Researchers are increasingly shifting from simple to complex models to better recapitulate diseases. As they move from immortalized cell lines to more physiologically relevant systems such as ...